製剤設計学講座

Keyphrases

1. Time-domain nuclear Magnetic Resonance (TD-NMR) 100%
2. Active Pharmaceutical Ingredients 61%
3. T2 Relaxation Time 54%
4. Tablet Properties 45%
5. Indomethacin 35%
6. Tensile Strength 30%
7. Crystalline State 25%
8. Relaxation Curve 22%
9. Mannitol 21%
10. Relaxation Behavior 21%
11. Disintegration Time 20%
12. T1 Relaxation Time 20%
13. Magnetic Resonance Imaging 20%
14. Solid Dispersion 19%
15. Relaxation Studies 18%
16. Kohonen Self-organizing Map 18%
17. Direct Compaction 18%
18. Wet Granules 18%
19. Disintegrant 17%
20. Granules 16%
21. Physical Mixture 15%
22. T2 Value 15%
23. Molecular Mobility 14%
24. Nanosuspension 13%
25. Acetylsalicylic Acid 13%
26. NMR Studies 13%
27. Nanoparticles 13%
28. Partial Least Squares Regression 12%
29. Least Absolute Shrinkage and Selection Operator (LASSO) 12%
30. Solid Dosage Form 12%
31. Critical Quality Attributes 12%
32. Granulation Process 12%
33. Powder Properties 12%
34. Relaxation Measurements 11%
35. Machine Learning 11%
36. Water Content 11%
37. Material Properties 10%
38. Base-free 10%
39. Crystalline Transformation 10%
40. Nondestructive Monitoring 10%
41. T2 Mapping 10%
42. Continuous Monitoring 10%
43. Operator Regression 10%
44. Crystallinity 10%
45. Nuclear Magnetic Resonance Relaxation 9%
46. Water Molecule 9%
47. Dispersion State 9%
48. Weight Variation 9%
49. Definitive Screening Design 9%
50. Tablet Weight 9%
51. Mini-tablets 9%
52. Temperature Recognition 9%
53. Size Recognition 9%
54. Superposition Principle 9%
55. Material Library 9%
56. Precise Prediction 9%
57. Machine Learning Applications 9%
58. Remimazolam Besylate 9%
59. Critical Material Attributes 9%
60. Agglomeration Process 9%
61. Non-destructive Investigation 9%
62. Imaging Monitoring 9%
63. Hybrid Mixer 9%
64. Ringer's Acetate 9%
65. Elastic Net Regression Model 9%
66. Storage Stability 9%
67. Hydrolytic Degradation 9%
68. Mixing Process 9%
69. Kinetic Analysis 9%
70. Higher-order Structure 9%
71. Water State 9%
72. Wet Granulation Method 9%
73. Pharmaceutical Emulsions 9%
74. Placebo 9%
75. Oral Jelly 9%
76. Concentrated Suspensions 9%
77. Total Occlusion 9%
78. Remimazolam 9%
79. Titanium Dioxide Nanoparticles 9%
80. Manufacturing Process 9%
81. Saccharide Recognition 9%
82. Prediction Method 9%
83. Humid Conditions 9%
84. Intravenous Catheter 9%
85. Critical Process Parameters 9%
86. 1H NMR Relaxation 9%
87. Powder Characterization 9%
88. Moisturizing Cream 9%
89. Quantitative Evaluation 9%
90. Ointment 9%
91. NMR Relaxometry 9%
92. Interaction Terms 9%
93. Pharmaceutical Ingredients 9%
94. Regularized Linear Regression 9%
95. Nanoparticle Concentration 9%
96. H+-ATPase 9%
97. Proton Pump Inhibitors 9%
98. Mixed State 9%
99. Tablet-based 9%
100. NMR Analysis 9%